Shapoval, O. S., & Vorontsova, L. L. (2015). Pathogenetic rationale for the use of immunomodulating and systemic enzyme therapy in treatment of nulliparous women with endometrioid ovary tumors. Journal of Education, Health and Sport, 5(1), 75–86. Retrieved from https://apcz.umk.pl/JEHS/article/view/2483